Quarterly Financial Results for Q2 2026: This 10-Q filing reports GE HealthCare Technologies Inc.'s financial performance for the six-month period ended June 30, 2026, and the specific quarter ended June 30, 2026, including revenue, operating results, and earnings data segmented by Products and Services. Balance Sheet and Financial Position: The filing contains consolidated balance sheet…

Our analysis rates this filing NEUTRAL. GE HealthCare Technologies presents a balanced, stable risk profile appropriate for a recently independent industrial healthcare equipment company. The identified risks are moderate in severity and largely represent normal operational management activities…

Concern level: ELEVATED (4.8/10). Key factors: Restructuring charges ongoing in H1 2026 across cost of revenue and SG&A, indicating active operational adjustments (severity 5/10); Hedged debt and interest rate exposure requiring active management, though hedging arrangements are in place (severity 4/10); Finance lease obligations present, though standard corporate practice (severity 3/10).

Notable risk changes: GE HealthCare Technologies Inc. is a recently separated entity (spun from GE Healthcare Holding LLC on June 3, 2022), now operating as independent public company - this is a structural change rather than a new risk; Company is in Q2 2026 reporting cycle with three business segments: AIS (Artificial Intelligence & Imaging Solutions), PDx (Precision Diagnostics), and PCS (Patient Care Solutions)…

The model predicts GEHC will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.